Kopin Corporation — Q1 2024 Form 10-Q
Business and period: Kopin develops and sells miniature displays, optical lenses, modules and subassemblies, and licenses related intellectual property for defense, industrial and consumer applications. This unaudited quarter ended March 30, 2024; comparisons are with the three months ended April 1, 2023.
Financial performance and position
| Metric | Q1 2024 | Prior-year quarter |
|---|---|---|
| Total revenue | $10.03 million | $10.76 million |
| Operating loss | $32.64 million | $2.83 million |
| Net loss | $32.55 million | $2.63 million |
| Net loss per share, basic and diluted | $0.27 | $0.03 |
| Cash used in operations | $3.11 million | $4.17 million |
- Revenue declined about 7%. Product revenue rose 18% to $9.03 million, but R&D revenue fell to $0.90 million from $2.90 million. Defense revenue increased to $8.23 million; industrial and consumer revenue declined.
- Product cost of revenue was 95% of product revenue, versus 87% a year earlier, reflecting higher excess and obsolete inventory reserves. Implied product gross margin was about 5%, compared with about 13%.
- SG&A increased to $7.23 million from $4.65 million, primarily due to $2.5 million more in legal fees, along with higher professional fees, marketing and stock compensation.
- The $32.55 million net loss includes a $24.8 million litigation accrual. Excluding that item, the quarter still reflected an operating loss; the filing does not present an adjusted earnings measure.
- At March 30, cash and cash equivalents were $14.12 million, restricted cash $0.75 million, and marketable debt securities $6.94 million on the balance sheet. The filing reports these resources together as $21.81 million, versus $17.90 million at year-end 2023.
- Working capital was negative $0.52 million, compared with positive $24.0 million at December 30, 2023. Current liabilities included $24.8 million of accrued litigation damages; total liabilities were $46.33 million and stockholders’ equity was $4.94 million.
- Cash from operations was negative $3.11 million. Investing activities provided $4.52 million, mainly from marketable-security sales, and the ATM stock issuance provided $7.24 million net. Cash, cash equivalents and restricted cash increased $8.66 million during the quarter.
- No conventional borrowings are identified in the presented balance sheet. Operating lease liabilities totaled $2.31 million. The company expects 2024 capital expenditures of $1–$2 million.
Material changes, outlook and risks
- BlueRadios litigation: On April 22, 2024, after quarter-end, a jury found for BlueRadios, awarding about $5.1 million in damages and recommending $19.7 million in disgorgement and exemplary damages. Kopin accrued the full $24.8 million in Q1 statements. No final judgment had been issued; the court was to determine the final amount after briefing. BlueRadios may also seek prejudgment interest, attorneys’ fees and equitable remedies. Kopin said it would argue for a reduction and was considering an appeal.
- Going concern: Management disclosed substantial doubt about Kopin’s ability to continue as a going concern, citing historical operating cash outflows, limited liquidity, the litigation exposure and uncertainty about raising capital. The company plans to seek financing, manage discretionary spending and consider cost reductions, asset sales or other strategic alternatives; it gave no assurance these efforts will succeed.
- Management expects to continue R&D investment in display products, overlay weapon sights and OLED technologies, while reducing spending may be necessary. No specific revenue or profitability guidance is provided.
- Remaining performance obligations were $31.1 million, expected to be recognized over the next 12 months; these government-contract amounts are subject to cancellation.
- Management reported that semiconductor shortages had improved but occasional supply disruptions could still affect shipments. Other cited risks include customer/program funding changes, foreign-exchange movements, and the need for additional capital. Kopin does not currently hedge foreign-currency risk.
- The company sold 3.08 million shares through its ATM program for $7.47 million gross proceeds, at an average $2.42 per share; the agreement terminated during the quarter. Management stated disclosure controls were effective and reported no material change in internal control over financial reporting.
Key facts for investors to verify
- The court’s final judgment and any prejudgment interest, attorneys’ fees or equitable remedies in the BlueRadios case, plus Kopin’s appeal plans and resulting cash obligations.
- Whether Kopin can raise capital or otherwise fund operations, and how planned cost controls affect R&D, staffing and business prospects.
- Cash runway and liquidity after litigation payments, operating losses and working-capital needs; also distinguish unrestricted cash from restricted cash and marketable securities.
- Whether the $31.1 million of remaining performance obligations converts to revenue as expected, given cancellation rights, and whether component availability affects shipments.
- Share-count and dilution disclosures: the filing reports 115.35 million shares outstanding at March 30 and 118.43 million as of May 3, while weighted-average shares used for Q1 EPS were 120.11 million. Investors should reconcile these figures and subsequent equity activity.